1 / 58

Ultrasonographic findings of the endometrium – how to evaluate / interpretate them ???

Ultrasonographic findings of the endometrium – how to evaluate / interpretate them ???. Dr . Ofer Lavie Division of Gyn-Surgical & Oncology Carmel Medical Center , HAIFA. Polyps and endometrial thickness what a confusing state ?. Dr . Ofer Lavie Division of Gyn-Surgical & Oncology

remy
Download Presentation

Ultrasonographic findings of the endometrium – how to evaluate / interpretate them ???

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Ultrasonographic findings of the endometrium – how to evaluate / interpretate them ??? Dr . Ofer Lavie Division of Gyn-Surgical & Oncology Carmel Medical Center , HAIFA

  2. Polyps and endometrial thickness what a confusing state ? Dr . Ofer Lavie Division of Gyn-Surgical & Oncology Carmel Medical Center , HAIFA

  3. Support ! different situationsby specific tools

  4. Menu • Thick endometrium Early detection- Screening Clinical outcome • Endometrial Polyps The risk of malignancy - Theory The risk of malignancy - Clinical To treat or not to treat ?

  5. Objective ? Pre Sym ? Post Thickness ? Pre Asym ? Post U.S & Endo ? Pre Sym ? Post Polyps ? Pre Asym ? Post

  6. Other options Pre Sym Pipell Post Thickness Do not touch Pre Asym ? Post U.S & Endo ? Pre Sym Hysteroscopy Post Polyps ? Pre Asym ? Post

  7. Menu • Thick endometrium Early detection- Screening Clinical outcome • Endometrial Polyps The risk of malignancy - Theory The risk of malignancy - Clinical To treat or not to treat ?

  8. Clinical outcome ? Asymptomatic thick endometrium - do we have to sample ? Removing the tumor Thick endo Sampling ? Early detection ?

  9. Different levels of endo. thickness

  10. Asymptomatic thick endometrium - do we have to sample ?

  11. Clinical outcome ? Asymptomatic thick endometrium - do we have to sample ? Removing the tumor Thick endo Sampling ? Early detection ?

  12. Screening for early detection • >75% EC pts present with stage I disease • 5YS 88% • Not much scope for decreasing mortality • May provide genuine reasurance - if sensitivity high • May minimise treatment if achieves earlier diagnosis

  13. Screening evidence • Minimal data on screening in high risk group • Limited data on EC screening in the general population • Unpublished data from UKCTOCS study

  14. Screening evidence-Endometrial Bx in thick endometrium (>6mm)

  15. Screening evidence-Endometrial Bx in thick endometrium (>6mm)

  16. TVU findings on EC in UKCTOCS Study of the general population • 48,190 postmenopausal women aged 50 -74 who had completed initial UKCTOCS scan • 9069 had a hysterectomy • Baseline TVS screens on 38,668 asymptomatic women • 82 women with abn (73 with EC, 5 complex hyperplasia, 4 Atypical hyperplasia) • Last TVS before EC diagnosis • Endometrial thickness (ET) in mms • Endometrial abnormality (EA) includes polyp; thickened, cystic, irregular or heterogeneous endometrium; fluid in cavity

  17. Endometrial Thickness on TVU Healthy women Endometrial Cancer

  18. EC Screening in UKCTOCS

  19. EC Screening recommendation-RCOG • There is no evidence based approach • In view of the high risk discuss the options of endometrial aspiration and TVU with women at risk • Offer annual TVU from 45y • Postmenopause 8-7mm cut off • Emphasise lack of evidence, risk of false positives and false negatives

  20. Clinical outcome ? Asymptomatic thick endometrium - do we have to sample ? Removing the tumor Thick endo Sampling ? Early detection ?

  21. Survival of Untreated Patients

  22. Natural Course of Patient with Untreated Endometrial Ca

  23. Early detection Prognosis • A lengthy survival of untreated patients with endometrial carcinoma indicates a slow natural progression of the disease. • The asymptomatic pre – treatment period should not influence the final outcome Endometrial endometrioid carcinoma : A glimpse at natural course Levy and Menczer AJOG 2006

  24. More evidence • UP to Date (Clinical features of endometrial ca) : 6-8mm may be sampled /or await for symptoms Mean endo thickness in 759 endo ca was 20mm • Cochrane 2006 >6mm in menopause more than 15 y >8 mm in menopause 5-15 y.

  25. CONCLUSIONS • No evidence for screening • No evidence for early detection value In asym thick endometrium • In post menopause endometrial sampling should be performed if endo thickness is above 8-10 mm (no HRT) • In late menopause be more active

  26. Other options ? Pre Sym Pipell Post Thickness Do not touch Pre Asym ? Post U.S & Endo ? Pre Sym Hysteroscopy Post Polyps ? Pre Asym ? Post

  27. Other options Pre Sym Pipell Post Thickness Do not touch Pre Asym No need for pipell Post U.S & Endo ? Pre Sym Hysteroscopy Post Polyps ? Pre Asym ? Post

  28. Other options Pre Sym Pipell Post Thickness Do not touch Pre Asym No need for pipell Post U.S & Endo ? Pre Sym Hysteroscopy Post Polyps ? Pre Asym ? Post

  29. Endometrial Polyps

  30. Menu • Thick endometrium Early detection- Screening Clinical outcome • Endometrial Polyps The risk of malignancy - Theory The risk of malignancy - Clinical To treat or not to treat ?

  31. Endometrial polyps - The risk of malignancy Clinical

  32. Conclusions • Percentage of carcinomatosis polyps 1-3% • Almost all symptomatic • All menopausal • If > 15 mm high risk?

  33. The clinical problem-Benign or Malignant

  34. What else can be helpful ? • Symptomatic Polyps • History : TAM, HNPCC • Large Polyps > 15 mm

  35. SMALL CYSTIC FORMATIONS AS A ULTRASONOGRAPHIC SIGN FOR BENIGN ENDOMETRIAL POLYPS Carmel Medical Center The Department of Obstetrics and Gynecology O.Lavie, R.Kedar, S.Cohen A.Sharon, M.Bardicef, D.Solomovich, A.Lissak and R.Auslander

  36. Objective • To evaluate the risk for endometrial carcinoma in endometrial polyps presenting with small cystic formation as demonstrated in transvaginal ultrasonography.

  37. Materials and Methods • Retrospective study • TVS photos with histologically proven endometrial polyps were assessed by two of the authors. • All polyps were examined for the presence of cystic formations and the presence of endometrial fluid. • The TVS finding were all compared to the hysteroscopic and to the final pathological reports.

  38. Study population • 141 patients with histologically proven endometrial polyps. • All women had TVS demonstrated endometrial polyps • Hysteroscopy was performed to all women • Mean age 61.7

  39. Results

  40. Conclusion • Cystic formation is a common finding in endometrial polyps (above 50% of polyps)

  41. Conclusion (2) • The cystic formations as demonstrated by TVS reflect the histological appearance of glandular atrophy.

  42. Conclusion (3) • In our study the ultrasonographic documentation of cystic formations in endometrial polyps suggests a benign finding.

  43. Conclusion (4) • In asymptomatic patients with a TVS finding of Endometrial Polyps and Cystic Formations a conservative management can be considered. • Symptomatic women with cystic formations ??

  44. What else can be helpful ? • Symptomatic Polyps • History : TAM, HNPCC • Large Polyps > 15 mm • Cystic formations in polyps

  45. Menu • Thick endometrium Early detection- Screening Clinical outcome • Endometrial Polyps The risk of malignancy - Clinical The risk of malignancy - Theory

  46. Endo Polyps – Pre-cancer state? Theory Is endo polyp a precancer state ???

  47. What are Pre-cancers states • Intermediate step in the continuous evolution of a neoplastic lineage • Pre-cancers are benign neoplasms in which the burden of genetic damage is insufficient for malignant behavior • Pre-cancers have monoclonal character and this has been shown for CIN, VIN etc.

  48. Monoclonality Monocional Procancer Polycional Normal Monocional Cancer Malignant Transformation Initiation

More Related